Franklin Biotechnology Discovery Fund Class A

 (MUTF:FBDIX)   Watch this mutual fund  
Find more results for MUTF:FBDIX

Performance

Trailing returns

1 day
   
-3.00%  
1 week   +1.96%
   
4 week   +7.55%
   
3 month   +2.10%
   
YTD   +15.29%
   
1 year   +32.51%
   
3 years*   +7.21%
   
5 years*   +17.99%
   
*annualized
Best 3 month return+32.60%  
Worst 3 month return-28.22%  

Morningstar statistics

Morningstar category: Health
  Return Risk Rating
3 years Below Average High
5 years Average High
10 years Above Average Above Average
Overall Average High
Morningstar style  Learn more
      Large
      Mid
      Small
Value Blend Growth  

Key statistics

Total assets1.29B 
Front load5.75%  
Deferred load-  
Expense ratio0.99%  
Management fee-  
Fund familyFranklin Templeton Investments 

Asset allocation

Cash2.49%  
Stocks96.30%  
Bonds0.00%  
Other1.22%  

Purchase information

Initial$1,000  
IRA Initial$250  
AIP Initial$50  
149.48-4.62(-3.00%)
Jun 26, 8:00PM EDT Overall Morningstar RatingTM

Description

The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified.
Fund filings (PDF) »
Asset managers:
Christopher Lee (Started: May 1, 2016)
Steven Kornfeld (Started: Sep 15, 2015)
Evan McCulloch (Started: Sep 15, 1997)
Advisor Company:
Franklin Advisers Inc
Fund family reports on Morningstar »
Franklin Templeton Investments, One Franklin Parkway, Building 970, 1st Floor, Rancho Cardova, CA 95670, USA

Risk

  1 year 3 years 5 years 10 years  
Alpha* -36.32 2.10 5.18 10.07
Beta* 2.75 1.40 1.28 0.72
Mean annual return 0.66 0.84 1.65 1.15
R-squared* 40.84 33.62 27.71 30.37
Standard deviation 24.22 26.04 24.63 22.10
Sharpe ratio 0.30 0.38 0.80 0.60
* Against standard index

Top 10 holdings

Security Net Assets  
Celgene Corp (CELG) 9.61%  
Biogen Inc (BIIB) 6.56%  
Incyte Corp (INCY) 6.40%  
Alexion Pharmaceuticals Inc (ALXN) 5.57%  
Tesaro Inc (TSRO) 5.30%  
Regeneron Pharmaceuticals Inc (REGN) 4.64%  
Gilead Sciences Inc (GILD) 4.16%  
Amgen Inc (AMGN) 4.14%  
Vertex Pharmaceuticals Inc (VRTX) 3.56%  
Illumina Inc (ILMN) 2.67%